AskVantage

AecorBio

AecorBio is a startup headquartered in Menlo Park, United States, founded in 2023. It has raised at least $2.5m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.

Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .

2023Founded
StartupStage
Menlo Park, United StatesHeadquarters
BiotechnologyIndustry
$2.5m+Raised (SEC filings)
SeedFunding stage
Biotechnology
See it on the interactive mapBook a Briefing

Funding

AecorBio has raised at least $2.5m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.

R&D ecosystem

AecorBio sits inside the Silicon Valley and the Bay Area R&D ecosystem in the Global R&D Labs Directory.

Other startups in Menlo Park

Related

Questions and answers

What does AecorBio do?

AecorBio is classed in biotechnology in its filings with the US Securities and Exchange Commission.

How much has AecorBio raised?

At least $2.5m, according to its Form D filings with the US Securities and Exchange Commission.

Where is AecorBio based?

AecorBio is headquartered in Menlo Park, United States.

When was AecorBio founded?

AecorBio was founded in 2023.

Source record: SEC EDGAR (Form D filings).

© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.